Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pemphigus Vulgaris (PV)”

12 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 12 results

Large-scale testing (Phase 3)Ended earlyNCT03762265
What this trial is testing

PRN1008 in Patients With Pemphigus

Who this might be right for
Pemphigus
Principia Biopharma, a Sanofi Company 131
Not applicableNot Yet RecruitingNCT06863454
What this trial is testing

Trichoscopy as a Monitoring Tool for Activity and Remission in Pemphigus Vulgaris: A Clinical Study Supported by Immunological Evaluation.

Who this might be right for
Pemphigus Vulgaris (PV)
Assiut University 62
Post-approval studies (Phase 4)UnknownNCT05303272
What this trial is testing

Evaluate Efficacy and Safety of Abatacept in Participants of Pemphigus Vulgaris (PV)

Who this might be right for
Pemphigus Vulgaris
Tongji Hospital 60
Large-scale testing (Phase 3)Ended earlyNCT01920477
What this trial is testing

Efficacy and Safety of Ofatumumab in Treatment of Pemphigus Vulgaris

Who this might be right for
Pemphigus Vulgaris
Novartis Pharmaceuticals 35
Testing effectiveness (Phase 2)Looking for participantsNCT04422912
What this trial is testing

A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)

Who this might be right for
Pemphigus Vulgaris
Cabaletta Bio 40
Large-scale testing (Phase 3)Study completedNCT02383589
What this trial is testing

Evaluate the Efficacy and Safety of Rituximab Versus Mycophenolate Mofetil (MMF) in Participants With Pemphigus Vulgaris (PV)

Who this might be right for
Pemphigus Vulgaris
Hoffmann-La Roche 135
Large-scale testing (Phase 3)Study completedNCT00683930
What this trial is testing

Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Patients With Active Pemphigus Vulgaris (PV)

Who this might be right for
Pemphigus Vulgaris (PV)
Hoffmann-La Roche 96
Not applicableStudy completedNCT06654817
What this trial is testing

Efficacy and Safety Evaluation of Anti-CD20 Monoclonal Antibody Combined with Azathioprine and Corticosteroids in the Treatment of Pemphigus Vulgaris

Who this might be right for
PemphigusPemphigus Vulgaris (PV)
Chao Ji 38
Not applicableLooking for participantsNCT07384221
What this trial is testing

Periodontal Status and Disease Severity in Pemphigus Vulgaris Patients

Who this might be right for
Pemphigus Vulgaris (PV)Periodontal Diseases
Saglik Bilimleri Universitesi 20
Not applicableUnknownNCT05284929
What this trial is testing

Human Leukocyte Antigen Class II (DRB1 and DQB1) Alleles and Haplotypes Frequencies in Patients With Pemphigus Vulgaris Among the Russian Population

Who this might be right for
PemphigusBullous PemphigoidStevens-Johnson Syndrome+1 more
Sechenov University 120
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06663943
What this trial is testing

Study on Pemphigus Treatment With Humanized CD38 Antibody CM313.

Who this might be right for
Pemphigus DiseasePemphigus Vulgaris (PV)
Chao Ji 100
Not applicableStudy completedNCT07428915
What this trial is testing

Evaluating Legit.Health Plus Support for Improving Diagnosis of Generalized Pustular Psoriasis and Other Skin Conditions Among Primary Care Physicians and Dermatologists

Who this might be right for
Pustular Psoriasis (PP)Generalized Pustular Psoriasis (GPP)Eczema Atopic Dermatitis+11 more
AI Labs Group S.L 15